Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.32%85.08B | 8.37%56.72B | 7.36%28.83B | 1.77%105.3B | 2.91%78.55B | 6.69%52.34B | 7.21%26.85B | 7.23%103.47B | 7.29%76.33B | 5.01%49.06B |
| Operating income | 8.32%85.08B | 8.37%56.72B | 7.36%28.83B | 1.77%105.3B | 2.91%78.55B | 6.69%52.34B | 7.21%26.85B | 7.23%103.47B | 7.29%76.33B | 5.01%49.06B |
| Cost of sales | -4.68%-30.37B | -4.71%-20.19B | -5.22%-10.35B | 2.27%-39.49B | 3.58%-29.01B | 2.56%-19.28B | 3.09%-9.84B | 7.60%-40.4B | 4.84%-30.09B | 5.50%-19.79B |
| Operating expenses | -4.68%-30.37B | -4.71%-20.19B | -5.22%-10.35B | 2.27%-39.49B | 3.58%-29.01B | 2.56%-19.28B | 3.09%-9.84B | 7.60%-40.4B | 4.84%-30.09B | 5.50%-19.79B |
| Gross profit | 10.45%54.71B | 10.51%36.53B | 8.60%18.48B | 4.35%65.81B | 7.13%49.53B | 12.93%33.06B | 14.23%17.02B | 19.51%63.06B | 16.99%46.24B | 13.55%29.27B |
| Selling expenses | 5.27%-10.73B | 16.62%-6.27B | 32.98%-2.7B | -1.28%-14.15B | -16.27%-11.33B | -21.81%-7.52B | -38.46%-4.02B | -4.23%-13.97B | 2.41%-9.74B | 0.63%-6.18B |
| Administrative expenses | 6.22%-3.18B | 12.02%-2.01B | 20.07%-956.34M | 7.13%-4.55B | 7.12%-3.39B | -6.23%-2.29B | -17.11%-1.2B | -4.35%-4.9B | -7.52%-3.65B | -1.19%-2.15B |
| Research and development expenses | -1.76%-13.28B | -1.30%-8.74B | -5.07%-4.39B | -6.31%-17.52B | -8.74%-13.05B | -12.69%-8.63B | -11.33%-4.17B | -9.61%-16.48B | -9.65%-12.01B | -9.73%-7.66B |
| Operating profit | 26.44%27.52B | 33.43%19.5B | 36.98%10.44B | 6.77%29.58B | 4.42%21.76B | 10.04%14.62B | 5.57%7.62B | 41.17%27.71B | 37.15%20.84B | 27.07%13.28B |
| Financing income | -21.23%2.95B | -18.24%2.01B | -16.96%1.06B | 19.43%4.92B | 31.05%3.75B | 43.95%2.46B | 64.63%1.28B | 91.68%4.12B | 88.03%2.86B | 77.51%1.71B |
| Special items of earning before tax | 2,977.48%2.74B | 368.54%1.58B | 144.69%949.87M | -45.55%1.21B | -103.65%-95.34M | -84.74%338.18M | 13.23%388.19M | -9.90%2.23B | -5.29%2.61B | 1,565.01%2.22B |
| Earning before tax | 30.68%33.21B | 32.63%23.1B | 34.06%12.45B | 4.88%35.72B | -3.41%25.41B | 1.20%17.42B | 11.38%9.29B | 40.44%34.06B | 35.11%26.31B | 52.76%17.21B |
| Tax | -17.32%-4.78B | -24.37%-3.47B | -28.21%-1.91B | -16.21%-5.46B | -12.26%-4.08B | -19.06%-2.79B | 8.76%-1.49B | 6.60%-4.7B | 10.68%-3.63B | 5.57%-2.34B |
| After-tax profit from continuing operations | 33.23%28.43B | 34.20%19.64B | 35.17%10.55B | 3.06%30.26B | -5.92%21.34B | -1.61%14.63B | 16.27%7.8B | 52.76%29.36B | 47.20%22.68B | 69.21%14.87B |
| Earning after tax | 33.23%28.43B | 34.20%19.64B | 35.17%10.55B | 3.06%30.26B | -5.92%21.34B | -1.61%14.63B | 16.27%7.8B | 47.95%29.36B | 41.46%22.68B | 57.98%14.87B |
| Minority profit | 123.99%910M | 207.67%733.07M | 45.84%245.61M | 1,041.76%558.74M | 364.84%406.26M | 287.03%238.26M | 480.68%168.41M | 88.00%-59.33M | 56.33%-153.4M | 53.32%-127.39M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | 0.96%29.7B | ---- | ---- | ---- | 49.23%29.42B | ---- | ---- |
| Profit attributable to shareholders | 31.47%27.52B | 31.33%18.9B | 34.94%10.3B | 0.96%29.7B | -8.33%20.93B | -4.03%14.39B | 13.02%7.63B | 44.64%29.42B | 39.36%22.83B | 54.84%15B |
| Basic earnings per share | 32.52%8.64 | 32.59%5.94 | 36.55%3.25 | 1.42%9.28 | -8.17%6.52 | -3.86%4.48 | 13.33%2.38 | 46.87%9.15 | 41.72%7.1 | 57.43%4.66 |
| Diluted earnings per share | 32.35%8.55 | 32.73%5.88 | 36.60%3.21 | 1.55%9.19 | -7.98%6.46 | -3.90%4.43 | 13.53%2.35 | 46.68%9.05 | 41.53%7.02 | 57.34%4.61 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.